Evidence map›Paper›PMID 31687638›Full record

ArticleJournal of the Endocrine Society2019

Sara Storvall, Eeva Ryhänen, Ilkka Heiskanen, Tiina Vesterinen, Frank V Bensch, Jukka Schildt, Soili Kytölä, Auli Karhu, Johanna Arola, Camilla Schalin-Jäntti

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Endocrine Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sara StorvallDepartment of Endocrinology, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Eeva RyhänenDepartment of Endocrinology, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Ilkka HeiskanenDepartment of Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Tiina VesterinenDepartment of Pathology, HUSLAB, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Frank V BenschDepartment of Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Jukka SchildtHUS Medical Imaging Center, Department of Clinical Physiology and Nuclear Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Soili KytöläLaboratory of Genetics, HUSLAB, Helsinki University Hospital, Helsinki, Finland.
Auli KarhuLaboratory of Genetics, HUSLAB, Helsinki University Hospital, Helsinki, Finland.
Johanna ArolaDepartment of Pathology, HUSLAB, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Camilla Schalin-JänttiDepartment of Endocrinology, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-2428-0161
University of Helsinki · FIHelsinki University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextParathyroid carcinoma (PC) is extremely rare. Prognosis is poor, with no known evidence-based systemic therapies. We previously reported complete remission in a patient with metastasized parathyroid carcinoma and high tumor

objectiveTo study DESIGN/

settingThe study included 12 patients: 7 with sporadic and 5 with familial primary hyperparathyroidism (two of the latter carried a

resultsOnly the previously published patient (patient 9) had high tumor

conclusionHigh

Indexed as

MGMT promoter methylationparathyroid carcinomatemozolomidetreatment

Identifiers

PMID31687638
PMCPMC6821197
OpenAlexW2965206905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.